Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

169 results about "Hog cholera virus" patented technology

Method for preparing live vaccines of hog cholera and product thereof

The invention discloses a method for preparing live vaccines of hog cholera and a product thereof. The preparation method comprises the following steps of: (1) culturing porcine passage cell lines; (2) inoculating the porcine passage cell lines with live vaccine production seed viruses of the hog cholera to obtain attenuated vaccine strains of the hog cholera; (3) performing virus multiplication on the attenuated vaccine strains of the hog cholera; (4) measuring the virus titer of multiplication virus suspension by adopting an immunofluorescence method; and (5) adding a freeze-drying protective agent and antibiotics into the virus suspension which is detected to be qualified for vaccine matching and freeze-drying. The preparation method has the advantages of producing the live vaccines of the hog cholera by using the cell lines so as to achieve small quality differences among batches and the characteristics of simple and stable process, easy operation, high yield, low cost, the feasibility and extendibility of industrial production and the like, and measuring the virus titer of the multiplication virus suspension by adopting the immunofluorescence method so as to achieve sensitive, fast, specific and accurate detection, high repeatability and reliable results. The live vaccines of the hog cholera prepared by the method can completely protect pigs from the attacks of violent hog cholera viruses.
Owner:武华

RT-RPA (reverse transcription recombinase polymerase amplification) detection kit for fast detecting high-pathogenicity porcine reproductive and respiratory syndrome virus and application thereof

The invention discloses an RT-RPA (reverse transcription recombinase polymerase amplification) detection kit for fast detecting a high-pathogenicity porcine reproductive and respiratory syndrome virus and application thereof. The kit comprises a pair of primers and a probe, the sequences of the primers are shown as SEQ ID NO.1 and SEQ ID NO.2, and the sequence of the probe is shown as SEQ ID NO.3. It is proved through experiments that the kit can detect adverse effects of the high-pathogenicity porcine reproductive and respiratory syndrome virus (HP-PRRSV), a hog cholera virus, a C-type porcine reproductive and respiratory syndrome virus, a porcine circovirus type II, a porcine pseudorabies virus and a foot and mouth disease virus in a specificity mode. It is proved through experiments that the kit can detect out templates of at least 70 copies at the temperature of 40 DEG C on the condition of 20 min amplification, and the conformity between the kit and RT-qPCR is high. This shows that the kit can detect HP-PRRSV fast, efficiently and sensitively and provides an effective technological means for differential diagnosis of HP-PRRSV.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

Fluorescent quantitative PCR rapid diagnosis reagent box for specific detection of classical swine fever virus wild virus infection

InactiveCN101328506ASolve the problem of false positives that cannot be ruled out for immunization vaccinesStrong specificityMicrobiological testing/measurementFluorescence/phosphorescenceNucleic acid detectionSpecific detection
The invention relates to a fluorescence quantitative PCR rapid diagnosis kit for specifically detecting the Hog cholera virus and wild virus infection and an application method thereof, belonging to the virus nucleic acid detection field. The fluorescence quantitative PCR rapid diagnosis kit is applied to the rapid quantitative detection of the CSFV wild virus clinically and in scientific research and can remove the false positive caused by the CSFV HCLV vaccine immunization. Compared with the prior art, the fluorescence quantitative PCR rapid diagnosis kit has the advantages that: the Hog cholera virus and wild virus infection and the vaccine immunization can be verified and diagnosed, the problem of the incapability of removing the false positive caused by the vaccine immunization is solved; the specificity is good, the high specificity hybridization double control of the primer high specificity amplification and the fluorescence probe is realized, the accuracy is high, the false positive is low; the sensitivity is high; the detection speed is high, only one hour is needed and two to three hours are needed when the extraction process of the nucleic acid and the preparation process of the cDNA are added; and the post treatment is not necessary, the processes such as hybridization, electrophoresis and photo are not necessary and no pollution is caused.
Owner:INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI

Heat-resistant freeze-drying protecting agent for vaccine and preparing method

The invention relates to a heat-resistant freeze-drying protecting agent for a vaccine and a preparing method and particularly relates to a heat-resistant freeze-drying protecting agent for a hog cholera vaccine, which is formed by mixing and proportioning the following substances according to weight percent: 1 to 2 percent of sodium carboxymethylcellulose, 4 to 6 percent of xylo-oligosaccharide,1 to 2 percent of glutamine, 0.2 to 0.8 percent of sodium selenite and the balance distilled water. The preparing method of the heat-resistant freeze-drying protecting agent for the hog cholera vaccine comprises the following steps of: (1) mixing the sodium carboxymethylcellulose and the distilled water as A liquid; (2) mixing the xylo-oligosaccharide and the distilled water as B liquid; (3) mixing the glutamine, the sodium selenite and the distilled water as C liquid; and (4) mixing the A liquid, the B liquid and the C liquid according to 1:1:1 (V/V) as the heat-resistant freeze-drying protecting agent. According to the heat-resistant freeze-drying protecting agent for the hog cholera live vaccine, which is designed by the invention, the activity of viruses can be kept in the freeze-drying process and the preserving process, and the reduction of the activity of a modified-live vaccine for hog cholera viruses is relieved.
Owner:青岛爱博生物科技有限公司

Prokaryotic expression protein of VP73 gene from African swine fever virus and preparation method thereof

The invention relates to a method for preparing a genetic engineering product, in particular to a prokaryotic expression protein of VP73 gene from African swine fever virus (ASFV) and a preparation method thereof. The preparation method comprises: artificially synthesizing the whole-length sequence of VP73 gene according to the sequence of the VP73 gene from ASFV in GenBank, constructing a recombinant expression vector pET32a-VP73, sequencing, verifying, transforming prokaryotic expression recipient bacteria E.coli BL21(DE3), and inducing expression by isopropyl-1-thio-beta-d-galactopyranoside (IPTG), wherein the molecular weight of the recombinant fusion protein is about 65KD. Protein purified by nickel column affinity chromatography can undergo a specific immune imprinting reaction with ASFV positive serum and avoid cross reaction with viruses such as swine fever virus, hog cholera virus, porcine circovirus, porcine reproductive and respiratory syndrome virus, swine influenza virus and pseudorabiesvirus. Experiments show the expressed protein has high detection sensitivity, and high specificity. When the antigen is used for detection, risk of spreading poison is avoided. And the antigen can be used as a detection antigen for use in an enzyme-linked immuno sorbent assay (ELISA) method for identifying an ASFV antibody.
Owner:FEED RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Real-time fluorescent quantitative PCR primer, kit and detection method for detecting porcine circovirus 3

The invention belongs to the technical field of molecular biology, and particularly relates to a real-time fluorescent quantitative PCR primer, kit and detection method for detecting the porcine circovirus 3. The nucleotide sequence of the real-time fluorescent quantitative PCR primer for detecting the porcine circovirus 3 is shown in SEQ ID NO.1-2. The invention further provides the kit containing the primer mentioned above and the detection method for detecting the porcine circovirus 3. The primer, the kit and the detection method are high in specificity, high in sensitivity and stable in repeatability, wave crests of the melting curve of amplified products are single, no primer dimer is caused, and the primer and the kit have no cross reaction with genomes of the porcine circovirus 2, the hog cholera virus, the porcine pseudorabies virus and the porcine reproductive and respiratory syndrome virus; sensitivity is 102 copies per microliter and is 100 times higher than that of the conventional PCR; and the variation coefficients of inter-group and intra-group repeated tests are all smaller than 3.0%. The foundation is laid for research on molecular epidemiology, prevention and control of the pestilence.
Owner:SOUTH CHINA AGRI UNIV

Ribonucleic acid interference (RNAi) for inhibiting porcine reproduction and respiratory syndrome virus replication and preparation method of RNAi

ActiveCN102660545AInhibit biological functionAnimal cellsInactivation/attenuationSlow virus infectionGreen monkey kidney
The invention discloses ribonucleic acid interference (RNAi) for inhibiting porcine reproductiion and respiratory syndrome virus (PRRSV) replication and a preparation method of RNAi, The RNAi comprises a small interfering RNA (siRNA) sequence. The preparation method comprises the steps of constructing a short hairpin RNA (shRNA) slow virus expression vector, preparing replication-defective slow virus, infecting slow virus Marc-145 cells (green monkey kidney cells) and the like. The invention also discloses a method for verifying the effect of inhibiting PRRSV from replication. The RNAi sequence has the obvious effect of inhibiting the PRRSV replication on sensitive cells. According to the invention, the exploration of RNA interference on in vitro and vivo replication of hog cholera virus is carried out, a slow-virtue-mediated stably-integrated RNA interfering technology for special conserved gene segments of a targeted hog cholera virus genome is constructed, and transgenic animals with the siRNA of targeted hog PRRSV are hopeful to construct. The necessary experimental data is accumulated for gene function research of RNAi applied to PRRSV and prevention and treatment of hog cholera, and early-stage preparation is provided for disease resistance breeding of animals.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

Method for preparing hogcholera vaccine

The invention discloses a method by adopting cell micro-carrier suspension culture system to prepare hogcholera (CSF) vaccine, which comprises the following steps that: (1) cells for preparing the vaccine is inoculated into a carrier tank containing culture liquid and micro-carriers, and the cells are uniformly mixed with the micro-carriers, so the cells are attached onto the micro-carriers; (2) when the quantity of the cells is increased to 5 to 40 times of the initial inoculation concentration, the hog cholera virus (HCLV) is inoculated onto the cells so as to breed the virus according to the virus multiple of infection (M.O.I) is of the ratio of 0.01 to 1; and (3) the prepared virus liquid is mixed, appropriate freezing drying protective agent is added, the virus liquid is quantitatively packed after being uniformly mixed with the freezing drying protective agent to be frozen and dried so as to obtain the hogcholera vaccine (CSF). The method which is adopted to produce the hogcholera vccine has the advantages that the concentration of the cultured cells is high, the cells can be continuously cultured, the virus yield is high, the immunity effect of the vaccine is high, the safety is good, and the like, and has complete immunity protection effect against the attack of the hog cholera virus.
Owner:PU LIKE BIO ENG

Indirect method of enzyme-linked immunosorbent assay for diagnosing antibody of hog cholera

The invention discloses the method for detecting antibody by using indirect enzyme-linked immunosorbent assay (ELISA) with recombinant protein being as antigen. The method includes following steps: in E2 gene of structural protein of hog cholera virus, a segment of gene of encoding antigen is connected to carrier of pGEM-T Easy plasmid so as to obtain recombinant plasmid; connecting purified recombinant plasmid to expression vector pPROEX-HTb, and shifting it in bacillus coli; culturing bacillus coli, expression carrier of the said segment of gene is expressed in bacillus coli; after picking up and denaturing the expressed protein by inclusion body, carrying out purifying, renaturing operations. Antibody in sample of hog blood serum is detected by using indirect ELISA under renatured fusion protein being as antigen. Advantages of the method are simple operation, easy of culturing and short production cycle.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products